Corbevax gets DCGI nod as heterologous Covid booster dose for adults

The vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for restricted use in emergency situation, the company said. “BE’s Corbevax is the first such vaccine in India to be approved as a heterologous Covid-19 booster,” it said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ndqVoP6
via IFTTT